Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 10374

1.

Optimal chemo-mobilization for the collection of peripheral blood stem cells in patients with multiple myeloma.

Song GY, Jung SH, Ahn SY, Jung SY, Yang DH, Ahn JS, Kim HJ, Lee JJ.

BMC Cancer. 2019 Jan 14;19(1):59. doi: 10.1186/s12885-019-5285-1.

2.

Stem Cells Derived from Dental Tissues.

Aydin S, Şahin F.

Adv Exp Med Biol. 2019 Jan 13. doi: 10.1007/5584_2018_333. [Epub ahead of print]

PMID:
30635857
3.

Relative contributions of adipose-resident CD146+ pericytes and CD34+ adventitial progenitor cells in bone tissue engineering.

Wang Y, Xu J, Chang L, Meyers CA, Zhang L, Broderick K, Lee M, Peault B, James AW.

NPJ Regen Med. 2019 Jan 7;4:1. doi: 10.1038/s41536-018-0063-2. eCollection 2019.

4.

Synergistic Cytotoxic Effect of Busulfan and the PARP inhibitor Veliparib in Myeloproliferative Neoplasms.

Patel PR, Senyuk V, Rodriguez NS, Oh AL, Bonetti E, Mahmud D, Barosi G, Mahmud N, Rondelli D.

Biol Blood Marrow Transplant. 2019 Jan 4. pii: S1083-8791(19)30009-6. doi: 10.1016/j.bbmt.2018.12.841. [Epub ahead of print]

PMID:
30615982
5.

Compounds targeting class II histone deacetylases do not cause panHDACI-associated impairment of megakaryocyte differentiation.

Simic D, Sang N.

Exp Hematol. 2019 Jan 4. pii: S0301-472X(19)30005-0. doi: 10.1016/j.exphem.2018.12.007. [Epub ahead of print]

PMID:
30611870
6.

Mobilized peripheral blood stem cell apheresis via Hickman catheter in pediatric patients.

Doberschuetz N, Soerensen J, Bonig H, Willasch A, Rettinger E, Pfirrmann V, Salzmann-Manrique E, Schäfer R, Klingebiel T, Bader P, Jarisch A.

Transfusion. 2019 Jan 4. doi: 10.1111/trf.15113. [Epub ahead of print]

PMID:
30610749
7.

A method for transplantation of human HSCs into zebrafish, to replace humanised murine transplantation models.

Hamilton N, Sabroe I, Renshaw SA.

Version 2. F1000Res. 2018 May 15 [revised 2018 Jan 1];7:594. doi: 10.12688/f1000research.14507.2. eCollection 2018.

8.

Bortezomib Is More Effective to Side Population of RPMI8226 Myeloma Cells than Classical Anti-myeloma Agents.

Kim KH, Cheong HJ, Lee MY, Lee N, Lee KT, Park SK, Won JH.

Anticancer Res. 2019 Jan;39(1):127-133. doi: 10.21873/anticanres.13088.

PMID:
30591449
9.

MISTRG Mice Support Engraftment and Assessment of Nonhuman Primate Hematopoietic Stem and Progenitor Cells.

Radtke S, Chan YY, Sippel TR, Kiem HP, Rongvaux A.

Exp Hematol. 2018 Dec 25. pii: S0301-472X(18)30988-3. doi: 10.1016/j.exphem.2018.12.003. [Epub ahead of print]

PMID:
30590092
10.

The Polycomb BMI1 Protein Is Co-expressed With CD26+ in Leukemic Stem Cells of Chronic Myeloid Leukemia.

Galimberti S, Grassi S, Baratè C, Guerrini F, Ciabatti E, Perutelli F, Ricci F, Del Genio G, Montali M, Barachini S, Giuliani C, Ferreri MI, Valetto A, Abruzzese E, Ippolito C, Iurlo A, Bocchia M, Sicuranza A, Martino B, Iovino L, Buda G, Salehzadeh S, Petrini M, Di Paolo A, Mattii L.

Front Oncol. 2018 Dec 6;8:555. doi: 10.3389/fonc.2018.00555. eCollection 2018.

11.

Remission of HIV-related naïve and high-risk Burkitt's lymphoma treated by autologous stem cell transplantation plus cART.

Min H, Yang J, Wang S, Tao P, Song Y, Wang X, Li H, Yang X, Dong X, Wang FS, Shi M, Wang X, Xu R.

Stem Cell Res Ther. 2018 Dec 20;9(1):353. doi: 10.1186/s13287-018-1089-5.

12.

Nuclear-cytoplasmic transport is a therapeutic target in myelofibrosis.

Yan D, Pomicter AD, Tantravahi S, Mason CC, Senina AV, Ahmann JM, Wang Q, Than H, Patel AB, Heaton W, Eiring AM, Clair PM, Gantz KC, Redwine HM, Swierczek SI, Halverson BJ, Baloglu E, Shacham S, Khorashad JS, Kelley TW, Salama ME, Miles RR, Boucher KM, Prchal JT, O'Hare T, Deininger MW.

Clin Cancer Res. 2018 Dec 18. pii: clincanres.0959.2018. doi: 10.1158/1078-0432.CCR-18-0959. [Epub ahead of print]

PMID:
30563936
13.

Bone Mesenchymal Stem Cell-Enriched β-Tricalcium Phosphate Scaffold Processed by the Screen-Enrich-Combine Circulating System Promotes Regeneration of Diaphyseal Bone Non-Union.

Wang X, Chu W, Zhuang Y, Shi D, Tao H, Jin C, Dai K, Zhao J, Gan Y.

Cell Transplant. 2018 Dec 17:963689718818096. doi: 10.1177/0963689718818096. [Epub ahead of print]

PMID:
30554525
14.

Barcoding of Macaque Hematopoietic Stem and Progenitor Cells: A Robust Platform to Assess Vector Genotoxicity.

Yabe IM, Truitt LL, Espinoza DA, Wu C, Koelle S, Panch S, Corat MAF, Winkler T, Yu KR, Hong SG, Bonifacino A, Krouse A, Metzger M, Donahue RE, Dunbar CE.

Mol Ther Methods Clin Dev. 2018 Oct 25;11:143-154. doi: 10.1016/j.omtm.2018.10.009. eCollection 2018 Dec 14.

15.

A Unique Human Immunoglobulin Heavy Chain Variable Domain-Only CD33 CAR for the Treatment of Acute Myeloid Leukemia.

Schneider D, Xiong Y, Hu P, Wu D, Chen W, Ying T, Zhu Z, Dimitrov DS, Dropulic B, Orentas RJ.

Front Oncol. 2018 Nov 22;8:539. doi: 10.3389/fonc.2018.00539. eCollection 2018.

16.

KDM5B Promotes Drug Resistance by Regulating Melanoma Propagating Cell Subpopulations.

Liu X, Zhang SM, McGeary MK, Krykbaeva I, Lai L, Jansen DJ, Kales SC, Simeonov A, Hall MD, Kelly DP, Bosenberg MW, Yan Q.

Mol Cancer Ther. 2018 Dec 6. pii: molcanther.0395.2018. doi: 10.1158/1535-7163.MCT-18-0395. [Epub ahead of print]

PMID:
30523048
17.

miR-27a is highly expressed in H1650 cancer stem cells and regulates proliferation, migration, and invasion.

Luo W, Zhang D, Ma S, Wang C, Zhang Q, Wang H, He K, Liu Z.

J Cancer Res Ther. 2018 Dec;14(Supplement):S1004-S1011. doi: 10.4103/0973-1482.199450.

18.

Pre-clinical Development of a Lentiviral Vector Expressing the Anti-sickling βAS3 Globin for Gene Therapy for Sickle Cell Disease.

Poletti V, Urbinati F, Charrier S, Corre G, Hollis RP, Campo Fernandez B, Martin S, Rothe M, Schambach A, Kohn DB, Mavilio F.

Mol Ther Methods Clin Dev. 2018 Nov 1;11:167-179. doi: 10.1016/j.omtm.2018.10.014. eCollection 2018 Dec 14.

19.

Paracrine Factors Released by Osteoblasts Provide Strong Platelet Engraftment Properties.

Abu-Khader A, Law KW, Jahan S, Manesia JK, Pasha R, Hovey O, Pineault N.

Stem Cells. 2018 Dec 5. doi: 10.1002/stem.2956. [Epub ahead of print]

PMID:
30520180
20.

CML hematopoietic stem cells expressing IL-1RAP can be targeted by chimeric antigen receptor (CAR)-engineered T cells.

Warda W, Larosa F, Neto Da Rocha M, Trad R, Deconinck E, Fajloun Z, Faure C, Caillot D, Moldovan M, Valmary-Degano S, Biichle S, Daguindau E, Garnache-Ottou F, Tabruyn S, Adotévi O, Deschamps M, Ferrand C.

Cancer Res. 2018 Dec 4. pii: canres.1078.2018. doi: 10.1158/0008-5472.CAN-18-1078. [Epub ahead of print]

PMID:
30514753

Supplemental Content

Loading ...
Support Center